drug

NIO752

1 story · latest Oct 9, 2026

Follow NIO752. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Novartis

Timeline

Novartis registers new Phase 2 NIO752 tauopathy trial; Egaten results, six studies update

Oct 9Weekly roundup, 8 itemsinclisiran iptacopanUpdated

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.